20
Apotex Pharmachem Inc, based in Canada, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ELIGLUSTAT TARTRATE (1:0.5), with a corresponding US DMF Number 32724.
Remarkably, this DMF maintains an Active status since its submission on May 01, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 31, 2018, and payment made on April 20, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II